A series of live symposia offers the opportunity for physicians, nurse practitioners, physician assistants, and other healthcare providers to gather to learn about current issues in primary care and to interact with one another for engaging discussions and collaborative learning.
Live regional meeting dates:
Check back for venue details as they become available.
Learn about the appropriate use of GLP-1 RAs to address elevated A1C, obesity, and CV risk, as well as strategies to improve tolerability and adherence.
Learn about the place of GLP-1 RAs in T2D; their impact on A1C, obesity, and CV risk; and strategies to improve tolerability and adherence.
Access expert recommendations for GLP-1 receptor agonist therapy for patients with type 2 diabetes.
In my practice, I choose the most effective treatment across the board to control blood sugar and reduce the risk for complications from renal, cardiovascular, and other common comorbidities.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.